DE60326226D1 - Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom - Google Patents
Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukomInfo
- Publication number
- DE60326226D1 DE60326226D1 DE60326226T DE60326226T DE60326226D1 DE 60326226 D1 DE60326226 D1 DE 60326226D1 DE 60326226 T DE60326226 T DE 60326226T DE 60326226 T DE60326226 T DE 60326226T DE 60326226 D1 DE60326226 D1 DE 60326226D1
- Authority
- DE
- Germany
- Prior art keywords
- prostaglandin
- glaucoma
- treatment
- combination
- antimicrobial agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36707102P | 2002-03-21 | 2002-03-21 | |
PCT/US2003/008935 WO2003079997A2 (en) | 2002-03-21 | 2003-03-21 | Prostaglandin f2 alpha analogs in combinaiotn with antimicrobials for treating glaucoma |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60326226D1 true DE60326226D1 (de) | 2009-04-02 |
Family
ID=28454834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60326226T Expired - Lifetime DE60326226D1 (de) | 2002-03-21 | 2003-03-21 | Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom |
Country Status (7)
Country | Link |
---|---|
US (1) | US20060264353A1 (de) |
EP (1) | EP1501530B1 (de) |
JP (1) | JP2005526092A (de) |
AT (1) | ATE422894T1 (de) |
AU (1) | AU2003222049B2 (de) |
DE (1) | DE60326226D1 (de) |
WO (1) | WO2003079997A2 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7060808B1 (en) * | 1995-06-07 | 2006-06-13 | Imclone Systems Incorporated | Humanized anti-EGF receptor monoclonal antibody |
US20030224001A1 (en) * | 1998-03-19 | 2003-12-04 | Goldstein Neil I. | Antibody and antibody fragments for inhibiting the growth of tumors |
ZA200007412B (en) * | 1998-05-15 | 2002-03-12 | Imclone Systems Inc | Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases. |
EP1218032A4 (de) * | 1999-05-14 | 2005-05-25 | Imclone Systems Inc | Behandlung von refraktären humanen tumoren mit antagonisten des epidermalen wachstumsfaktorrezeptors |
AU9500201A (en) * | 2000-08-09 | 2002-02-18 | Imclone Systems Inc | Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
US20080008704A1 (en) * | 2001-03-16 | 2008-01-10 | Mark Rubin | Methods of treating colorectal cancer with anti-epidermal growth factor antibodies |
EP1622941A2 (de) * | 2003-03-20 | 2006-02-08 | ImClone Systems Incorporated | Methode zur produktion von anti-egfr antikörpern |
MXPA06010715A (es) * | 2004-03-19 | 2007-05-23 | Imclone Systems Inc | Anticuerpo del receptor del factor de crecimiento humano anti-epidermico. |
US20070015838A1 (en) * | 2005-07-14 | 2007-01-18 | Allergan, Inc. | Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure |
US8138148B2 (en) | 2005-08-16 | 2012-03-20 | Copenhagen University | GDNF derived peptides |
EP1941876A1 (de) * | 2006-12-28 | 2008-07-09 | Lacer, S.A. | Isosorbidmononitrit Derivate zur Behandlung von der Inflammation und okularen Hypertension |
ES2671372T3 (es) * | 2007-07-26 | 2018-06-06 | Azad Pharma Ag | Preparaciones farmacéuticas que comprenden disoluciones de hipoclorito activadas electroquímicamente |
MX2010007442A (es) | 2008-01-07 | 2010-12-21 | Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg | Uso de peptidos para promover la curacion de heridas. |
US9090670B2 (en) | 2008-01-07 | 2015-07-28 | Rapid Pathogen Screening, Inc. | Use of peptides for promoting wound healing |
EP2288333B1 (de) * | 2008-05-14 | 2011-12-28 | Peter Thomas Roth Labs, Llc | Auf prostaglandin basierende zusammensetzung und verfahren zu ihrer verwendung |
DE102009007381A1 (de) * | 2009-01-29 | 2010-08-05 | Amp-Therapeutics Gmbh & Co. Kg | Antibiotische Peptide |
CA2773737C (en) | 2009-09-09 | 2021-11-16 | Pharmain Corporation | Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
US20130310327A1 (en) | 2012-05-18 | 2013-11-21 | Rapid Pathogen Screening, Inc. | Histatin for Corneal Wound Healing and Ocular Surface Disease |
WO2015048736A1 (en) * | 2013-09-30 | 2015-04-02 | Irix Pharmaceuticals, Inc. | Novel synthesis routes for prostaglandins and prostaglandin intermediates using metathesis |
CA2935957C (en) | 2014-01-10 | 2023-01-03 | Manistee Partners Llc | Treatment of migraines using topical administration of prostaglandin f2alpha analogs |
CN106456710A (zh) * | 2014-06-20 | 2017-02-22 | 库柏维景国际控股公司 | 用于治疗眼部感染的眼用组合物 |
IT201700006360A1 (it) * | 2017-01-20 | 2018-07-20 | Italdevice Srl | Composizione per uso oftalmico |
AU2022359566A1 (en) * | 2021-10-08 | 2024-02-29 | Bonafide Health, Llc | Products and methods for extending the shelf life of water-sensitive products |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4025516A (en) * | 1975-06-23 | 1977-05-24 | The John C. Sheehan Institute For Research, Inc. | Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans |
US4116979A (en) * | 1975-06-23 | 1978-09-26 | Sheehan Institute For Research, Inc. | Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans |
US4049678A (en) * | 1976-03-29 | 1977-09-20 | The Upjohn Company | 9-Deoxy-PGD-type, 1,15-lactones |
US4032543A (en) * | 1975-06-23 | 1977-06-28 | The Upjohn Company | Pg-type 1,11-lactones |
JP3361830B2 (ja) * | 1992-03-30 | 2003-01-07 | 生化学工業株式会社 | 抗菌性組成物及びそれを有効成分とする薬剤 |
US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
US5643875A (en) * | 1994-01-24 | 1997-07-01 | Friedmann; Nadav | Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
US5652209A (en) * | 1994-04-29 | 1997-07-29 | University Of Miami | Use of secretory products of human lacrimal gland acinar epithelia for tear replacement therapy |
US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
ATE326972T1 (de) * | 1997-10-13 | 2006-06-15 | R Tech Ueno Ltd | Heilende zusammensetzung für intraokulare hypertension oder glaukom |
WO2002000839A2 (en) * | 2000-06-28 | 2002-01-03 | The Regents Of The University Of California | Statement as to federally sponsored research |
US20020035148A1 (en) * | 2000-07-20 | 2002-03-21 | Ryuji Ueno | Treatment of ocular hypertension |
AR035541A1 (es) * | 2000-11-13 | 2004-06-16 | Pharmacia Ab | Un metodo de tratamiento para pacientes que sufren de glaucoma severo o necesitan una reduccion de la presion intraocular (pio) y el uso de una combinacion de agentes reductores de la pio |
-
2003
- 2003-03-21 AT AT03718033T patent/ATE422894T1/de not_active IP Right Cessation
- 2003-03-21 WO PCT/US2003/008935 patent/WO2003079997A2/en active IP Right Grant
- 2003-03-21 EP EP03718033A patent/EP1501530B1/de not_active Expired - Lifetime
- 2003-03-21 DE DE60326226T patent/DE60326226D1/de not_active Expired - Lifetime
- 2003-03-21 JP JP2003577829A patent/JP2005526092A/ja active Pending
- 2003-03-21 AU AU2003222049A patent/AU2003222049B2/en not_active Ceased
- 2003-03-21 US US10/508,667 patent/US20060264353A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003079997A3 (en) | 2004-02-12 |
EP1501530A2 (de) | 2005-02-02 |
ATE422894T1 (de) | 2009-03-15 |
JP2005526092A (ja) | 2005-09-02 |
AU2003222049B2 (en) | 2007-05-31 |
EP1501530A4 (de) | 2006-05-03 |
US20060264353A1 (en) | 2006-11-23 |
WO2003079997A2 (en) | 2003-10-02 |
AU2003222049A1 (en) | 2003-10-08 |
EP1501530B1 (de) | 2009-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60326226D1 (de) | Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom | |
DE69434228D1 (de) | Verwendung von Fluprostenolisopropylester zur Herstellung eines Arzneimittels zur Behandlung von Glaukom und okularer Hypertension | |
ES2178291T3 (es) | Uso de acidos 3-benzoil-aceticos, esteres, o amidas para el tratamiento del glaucoma glc1a. | |
BR0310047A (pt) | Análogos de 8-azaprostaglandina como agentes para diminuição de pressão intra-ocular | |
WO2000027424B1 (en) | Upregulation of endogenous prostaglandins to lower intraocular pressure | |
BR0209709A (pt) | Composições hipotensivas de lipìdio e timolol e métodos de uso das mesmas | |
BRPI0418245A (pt) | nitróxi-derivados de prostaglandina | |
NO20006544D0 (no) | C-terminalt modifiserte oksamyldipeptider som inhibitorer av ICE/ced-3 familien av cystein proteaser | |
EP2325651A3 (de) | Zusammensetzungen und verfahren zur stabilisierung von transthyretin und zur hemmung von transthyretin-fehlfaltung | |
CA2613464A1 (en) | Treatment of dry eye | |
RU2004134733A (ru) | Агенты, которые регулируют, ингибируют или модулируют активность и/или экспрессию факторов роста соединительной ткани (фрст), в качестве уникальных средств для снижения внутриглазного давления и лечения глаукоматозных ретинопатий/оптических невропатий | |
DE69719931D1 (de) | Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren | |
EP0824910A3 (de) | Verwendung eines Krill-Enzyms zur Behandlung von Zahnbelag | |
WO2003072066A3 (en) | Compositions and methods for the treatment of glaucoma and ocular hypertension | |
ATE169815T1 (de) | Ophthalmische zusammensetzungen enthaltend als wirkstoff vitamin-e oder ester davon | |
DE60219614D1 (de) | 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes | |
FR2754712B1 (fr) | Compositions ophtalmiques | |
ATE453395T1 (de) | 3, 7 oder 3 und 7 thia- oder oxaprostansäure derivate als mittel zur senkung des augeninnendrucks | |
BR0315864A (pt) | Composições e processos para a modificação efeitos tóxicos de compostos proteináceos | |
AU631738B2 (en) | Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis | |
ATE216889T1 (de) | Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension | |
EP2062872A3 (de) | Verwendung von Bisaminen zur Verstärkung der antimikrobiellen Wirkung von wässrigen Zusammensetzungen | |
DE69834638D1 (de) | Heilende zusammensetzung für intraokulare hypertension oder glaukom | |
WO1995034302A3 (en) | Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators | |
WO2006136175A3 (en) | Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |